Nuritas and Professor Graeme Close Launch Clinical Study Evaluating Bioactive Peptides in Longevity and Healthy Aging

Liverpool John Moores University and Nuritas announced a new research collaboration to study PeptiStrong®’s potential to support functional strength, muscle health, and longevity in adults aged 60–85. The article frames the work as “landmark” research, but provides limited financial or trial outcome details. Overall, it’s a modest positive development likely more relevant to product credibility than near-term earnings.

Analysis

Liverpool John Moores University and Nuritas announced a new research collaboration to study PeptiStrong®’s potential to support functional strength, muscle health, and longevity in adults aged 60–85. The article frames the work as “landmark” research, but provides limited financial or trial outcome details. Overall, it’s a modest positive development likely more relevant to product credibility than near-term earnings.